Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland · Delayed Price · Currency is PLN 77.90
-0.40 (-0.51%)
May 21, 2026, 4:37 PM CET
WSE:CTX Revenue
In the year 2025, Captor Therapeutics Spolka Akcyjna had annual revenue of 4.66M PLN, down -70.55%. Captor Therapeutics Spolka Akcyjna had revenue of 44.00K in the quarter ending December 31, 2025, a decrease of -98.51%.
Revenue
4.66M
Revenue Growth
-70.55%
P/S Ratio
104.98
Revenue / Employee
51.21K
Employees
91
Market Cap
489.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.66M | -11.17M | -70.55% |
| Dec 31, 2024 | 15.83M | 2.62M | 19.88% |
| Dec 31, 2023 | 13.20M | 4.04M | 44.15% |
| Dec 31, 2022 | 9.16M | 5.17M | 129.75% |
| Dec 31, 2021 | 3.99M | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BIOTON | 282.52M |
| Ryvu Therapeutics | 87.70M |
| Synthaverse | 42.01M |
| Mabion | 15.76M |
| Molecure | 6.52M |
| Urteste | 1.80M |
| Pharmena | 1.58M |
| Poltreg | 250.00K |
Captor Therapeutics Spolka Akcyjna News
- 21 days ago - Captor Therapeutics Spolka Akcyjna Annual report: Q4 2025 - Filings
- 21 days ago - Captor Therapeutics Spolka Akcyjna Slides: Q4 2025 - Filings
- 6 months ago - Captor Therapeutics Spolka Akcyjna Quarterly report: Q3 2025 - Filings
- 8 months ago - Captor Therapeutics Spolka Akcyjna Slides: Corporate presentation - Filings
- 8 months ago - Captor Therapeutics Spolka Akcyjna Quarterly report: Q2 2025 - Filings
- 1 year ago - Captor Therapeutics Spolka Akcyjna Quarterly report: Q1 2025 - Filings